InDanio Bioscience Inc is a privately-held in vivo drug discovery company.
Business Model:
Revenue: $0
Employees: 1-10
Address: Address 160 College Street
City: Toronto
State: ontario
Zip: M5S 3E1
Country: CA
InDanio Bioscience Inc., is a privately-held in vivo drug discovery company dedicated to developing New Chemical Entities (NCEs) targeting the pharmaceutically-important Nuclear Receptor (NR) protein families. Their proprietary, Ligand Trap system, which includes 48 transgenic zebrafish lines, each singularly expressing one of the 48 human Nuclear Receptors, allows simultaneous assessment of drug delivery, stability, specificity, tissue-selectivity and toxicity. Selective, highest-value target lines are being used to identify, extract and characterize new hormonal regulators, as well as to identify new tissue-selective drugs, co-factors and mechanisms of action for each Nuclear Receptor.
Contact Phone:
+14169785531
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2014 | Grant | 2 | $490k |
CQDM Ontario Centres of Excellence CQDM Ontario Centres of Excellence |
10/2010 | Grant | $0 |
Ontario Genomics Ontario Genomics |
10/2010 | Grant | 1 | $100k |
Ontario Genomics Ontario Genomics |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|